Skip to content

To compare two different percentage of glycolic acid chemical peel in the treatment of periorbital hyperpigmentation

Comparison of 35% and 20% Glycolic acid peel in the treatment Of Periorbital hyperpigmentation - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062648
Enrollment
60
Registered
2024-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L818- Other specified disorders of pigmentation

Interventions

Intervention1: Glycolic acid: Topical 35% Glycolic acid peel is applied 3 weekly for 4 sessions in right lower lid of periorbital hyperpigmentation ( Aged 18-60 Years) Control Intervention1: Glycolic

Sponsors

DR BSA Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed cases of periorbital hyperpigmentation (POH)aged 18-60 years

Exclusion criteria

Exclusion criteria: 1.Patients on topical or systemic treatment for POH in the past 1 month. 2. Patients with unilateral POH. 3.History of allergy to glycolic acid. 4.Pregnancy and lactation. 5. Patients with photosensitive disorders. 6.Active viral or bacterial or fungal infections on face.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of 35% glycolic acid peel and 20% glycolic acid peel administered 3 weekly for four sessions in the treatment of periorbital hyperpigmentation (aged 18-60) as assessed by physician’s global assessment at 12 weeks follow-up.Timepoint: 0 and 12 weeks

Secondary

MeasureTime frame
To compare the safety of 35% glycolic acid peel & 20% glycolic acid peel in patients studied Timepoint: 3,6,9 & 12 weeks

Countries

India

Contacts

Public ContactDr. Lulua Safar

Dr. Baba Saheb Ambedkar Medical College and Hospital

viveksagar_sagar@yahoo.co.in9210338647

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026